These new medications build on that, marketing that obesity is a disease and not the persons fault
For comparison, combining multiple appetite-modifying agents often creates unpredictable effects on hunger, energy intake, and metabolic rate
Challenge of GLP1 storage and transport temperature monitoring Semaglutide formulations, like many biologics, are sensitive to temperature variations (refs
Waiting until you feel hungry can lead to undereating, affecting your progress
That body of evidence does not independently validate FeelGood's compounded formulations, specific dosing, or individual outcomes, which haven't been evaluated by the FDA
In Q1 2025, Zepbound generated $2.3 billion and Mounjaro $3.8 billion, with Lilly capturing 53% of the U.S